| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 459 | 450 | 431 | 433 | 411 | 390 | 440 | 485 | 445 | 476 | 468 | 520 | |
Growth YoY Revenue Growth YoY% | 15.1 | 5.0 | 1.2 | -10.2 | -10.6 | -13.2 | 1.9 | 12.0 | 8.5 | 21.9 | 6.3 | 7.3 |
| 397 | 401 | 384 | 392 | 399 | 391 | 422 | 442 | 414 | 426 | 426 | 474 | |
| 63 | 49 | 48 | 40 | 12 | -1 | 18 | 43 | 32 | 50 | 41 | 46 | |
OPM OPM% | 13.7 | 10.9 | 11.1 | 9.3 | 2.9 | -0.2 | 4.0 | 8.9 | 7.1 | 10.4 | 8.8 | 8.9 |
| -6 | 22 | 1 | 2 | 2 | 2 | 2 | 0 | -5 | 4 | 100 | 39 | |
Interest Expense Interest ExpenseCr | 10 | 12 | 14 | 18 | 16 | 18 | 26 | 25 | 26 | 46 | 28 | 27 |
Depreciation DepreciationCr | 24 | 26 | 28 | 29 | 29 | 29 | 30 | 32 | 32 | 32 | 35 | 34 |
PBT PBTCr | 23 | 33 | 7 | -5 | -31 | -46 | -37 | -14 | -31 | -25 | 78 | 24 |
| 7 | 11 | 5 | 5 | -3 | -4 | 0 | -4 | -2 | -1 | 12 | 5 | |
| 16 | 22 | 2 | -10 | -28 | -41 | -36 | -9 | -29 | -24 | 65 | 19 | |
Growth YoY PAT Growth YoY% | -44.7 | -14.7 | -92.5 | -128.4 | -282.5 | -287.6 | -2,097.3 | 8.0 | -3.7 | 42.7 | 280.0 | 311.4 |
NPM NPM% | 3.4 | 4.9 | 0.4 | -2.3 | -6.9 | -10.6 | -8.3 | -1.9 | -6.6 | -5.0 | 14.0 | 3.7 |
| 1.7 | 2.4 | 0.2 | -1.1 | -3.1 | -4.5 | -3.9 | -1.0 | -3.2 | -2.6 | 7.1 | 2.1 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 459 | 450 | 431 | 433 | 411 | 390 | 440 | 485 | 445 | 476 | 468 | 520 | |
Growth YoY Revenue Growth YoY% | 15.1 | 5.0 | 1.2 | -10.2 | -10.6 | -13.2 | 1.9 | 12.0 | 8.5 | 21.9 | 6.3 | 7.3 |
| 397 | 401 | 384 | 392 | 399 | 391 | 422 | 442 | 414 | 426 | 426 | 474 | |
| 63 | 49 | 48 | 40 | 12 | -1 | 18 | 43 | 32 | 50 | 41 | 46 | |
OPM OPM% | 13.7 | 10.9 | 11.1 | 9.3 | 2.9 | -0.2 | 4.0 | 8.9 | 7.1 | 10.4 | 8.8 | 8.9 |
| -6 | 22 | 1 | 2 | 2 | 2 | 2 | 0 | -5 | 4 | 100 | 39 | |
Interest Expense Interest ExpenseCr | 10 | 12 | 14 | 18 | 16 | 18 | 26 | 25 | 26 | 46 | 28 | 27 |
Depreciation DepreciationCr | 24 | 26 | 28 | 29 | 29 | 29 | 30 | 32 | 32 | 32 | 35 | 34 |
PBT PBTCr | 23 | 33 | 7 | -5 | -31 | -46 | -37 | -14 | -31 | -25 | 78 | 24 |
| 7 | 11 | 5 | 5 | -3 | -4 | 0 | -4 | -2 | -1 | 12 | 5 | |
| 16 | 22 | 2 | -10 | -28 | -41 | -36 | -9 | -29 | -24 | 65 | 19 | |
Growth YoY PAT Growth YoY% | -44.7 | -14.7 | -92.5 | -128.4 | -282.5 | -287.6 | -2,097.3 | 8.0 | -3.7 | 42.7 | 280.0 | 311.4 |
NPM NPM% | 3.4 | 4.9 | 0.4 | -2.3 | -6.9 | -10.6 | -8.3 | -1.9 | -6.6 | -5.0 | 14.0 | 3.7 |
| 1.7 | 2.4 | 0.2 | -1.1 | -3.1 | -4.5 | -3.9 | -1.0 | -3.2 | -2.6 | 7.1 | 2.1 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 1,008 | 1,075 | 1,042 | 968 | 1,107 | 1,242 | 1,541 | 1,669 | 1,817 | 1,665 | 1,845 | 1,909 |
Growth Revenue Growth% | 17.6 | 6.6 | -3.0 | -7.0 | 14.3 | 12.2 | 24.1 | 8.3 | 8.9 | -8.4 | 10.8 | 10.6 |
| 838 | 918 | 907 | 892 | 983 | 1,017 | 1,213 | 1,383 | 1,573 | 1,566 | 1,704 | 1,740 | |
| 170 | 156 | 135 | 77 | 123 | 224 | 327 | 286 | 244 | 99 | 142 | 169 | |
OPM OPM% | 16.9 | 14.6 | 12.9 | 7.9 | 11.1 | 18.1 | 21.3 | 17.1 | 13.4 | 6.0 | 7.7 | 8.8 |
| 2 | 4 | 5 | 6 | 2 | 3 | 2 | 2 | 21 | 6 | 0 | 137 | |
Interest Expense Interest ExpenseCr | 12 | 6 | 24 | 21 | 26 | 22 | 14 | 25 | 38 | 66 | 122 | 127 |
Depreciation DepreciationCr | 61 | 63 | 68 | 72 | 71 | 73 | 79 | 71 | 92 | 114 | 126 | 133 |
PBT PBTCr | 99 | 91 | 48 | -9 | 29 | 132 | 237 | 193 | 136 | -74 | -107 | 46 |
| 17 | 14 | 7 | -6 | 4 | 39 | 82 | 51 | 39 | 4 | -8 | 14 | |
PAT PATCr | 82 | 77 | 41 | -3 | 24 | 93 | 155 | 142 | 97 | -78 | -99 | 32 |
Growth PAT Growth% | -1.1 | -6.0 | -46.6 | -107.1 | 930.5 | 285.8 | 66.4 | -8.1 | -31.8 | -180.4 | -26.6 | 127.6 |
NPM NPM% | 8.1 | 7.2 | 4.0 | -0.3 | 2.2 | 7.5 | 10.1 | 8.5 | 5.3 | -4.7 | -5.3 | 1.7 |
| 8.9 | 8.4 | 4.5 | -0.3 | 2.6 | 10.1 | 16.8 | 15.4 | 10.5 | -8.5 | -10.7 | 3.4 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 1,008 | 1,075 | 1,042 | 968 | 1,107 | 1,242 | 1,541 | 1,669 | 1,817 | 1,665 | 1,845 | 1,909 |
Growth Revenue Growth% | 17.6 | 6.6 | -3.0 | -7.0 | 14.3 | 12.2 | 24.1 | 8.3 | 8.9 | -8.4 | 10.8 | 10.6 |
| 838 | 918 | 907 | 892 | 983 | 1,017 | 1,213 | 1,383 | 1,573 | 1,566 | 1,704 | 1,740 | |
| 170 | 156 | 135 | 77 | 123 | 224 | 327 | 286 | 244 | 99 | 142 | 169 | |
OPM OPM% | 16.9 | 14.6 | 12.9 | 7.9 | 11.1 | 18.1 | 21.3 | 17.1 | 13.4 | 6.0 | 7.7 | 8.8 |
| 2 | 4 | 5 | 6 | 2 | 3 | 2 | 2 | 21 | 6 | 0 | 137 | |
Interest Expense Interest ExpenseCr | 12 | 6 | 24 | 21 | 26 | 22 | 14 | 25 | 38 | 66 | 122 | 127 |
Depreciation DepreciationCr | 61 | 63 | 68 | 72 | 71 | 73 | 79 | 71 | 92 | 114 | 126 | 133 |
PBT PBTCr | 99 | 91 | 48 | -9 | 29 | 132 | 237 | 193 | 136 | -74 | -107 | 46 |
| 17 | 14 | 7 | -6 | 4 | 39 | 82 | 51 | 39 | 4 | -8 | 14 | |
PAT PATCr | 82 | 77 | 41 | -3 | 24 | 93 | 155 | 142 | 97 | -78 | -99 | 32 |
Growth PAT Growth% | -1.1 | -6.0 | -46.6 | -107.1 | 930.5 | 285.8 | 66.4 | -8.1 | -31.8 | -180.4 | -26.6 | 127.6 |
NPM NPM% | 8.1 | 7.2 | 4.0 | -0.3 | 2.2 | 7.5 | 10.1 | 8.5 | 5.3 | -4.7 | -5.3 | 1.7 |
| 8.9 | 8.4 | 4.5 | -0.3 | 2.6 | 10.1 | 16.8 | 15.4 | 10.5 | -8.5 | -10.7 | 3.4 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
Reserves ReservesCr | 558 | 633 | 657 | 642 | 661 | 751 | 886 | 1,010 | 1,091 | 1,004 | 921 | 1,003 |
| 303 | 390 | 416 | 446 | 459 | 407 | 425 | 425 | 612 | 808 | 1,053 | 972 | |
| 61 | 155 | 146 | 152 | 133 | 139 | 157 | 205 | 422 | 604 | 609 | 625 | |
| 941 | 1,197 | 1,236 | 1,258 | 1,272 | 1,315 | 1,486 | 1,658 | 2,145 | 2,430 | 2,593 | 2,613 | |
| 465 | 572 | 537 | 538 | 563 | 623 | 774 | 814 | 955 | 1,001 | 1,193 | 1,226 | |
| 476 | 625 | 699 | 720 | 708 | 693 | 712 | 845 | 1,190 | 1,429 | 1,400 | 1,387 | |
| 941 | 1,197 | 1,236 | 1,258 | 1,272 | 1,315 | 1,486 | 1,658 | 2,145 | 2,430 | 2,593 | 2,613 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
Reserves ReservesCr | 558 | 633 | 657 | 642 | 661 | 751 | 886 | 1,010 | 1,091 | 1,004 | 921 | 1,003 |
| 303 | 390 | 416 | 446 | 459 | 407 | 425 | 425 | 612 | 808 | 1,053 | 972 | |
| 61 | 155 | 146 | 152 | 133 | 139 | 157 | 205 | 422 | 604 | 609 | 625 | |
| 941 | 1,197 | 1,236 | 1,258 | 1,272 | 1,315 | 1,486 | 1,658 | 2,145 | 2,430 | 2,593 | 2,613 | |
| 465 | 572 | 537 | 538 | 563 | 623 | 774 | 814 | 955 | 1,001 | 1,193 | 1,226 | |
| 476 | 625 | 699 | 720 | 708 | 693 | 712 | 845 | 1,190 | 1,429 | 1,400 | 1,387 | |
| 941 | 1,197 | 1,236 | 1,258 | 1,272 | 1,315 | 1,486 | 1,658 | 2,145 | 2,430 | 2,593 | 2,613 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 112 | 89 | 123 | 132 | 123 | 82 | 174 | 179 | 157 | 95 | 192 | |
| -111 | -171 | -136 | -104 | -56 | -67 | -121 | -208 | -434 | -339 | -102 | |
| -2 | 132 | -39 | -16 | -64 | -30 | -44 | 23 | 280 | 241 | -77 | |
Net Cash Flow Net Cash FlowCr | 0 | 50 | -52 | 12 | 3 | -14 | 8 | -7 | 3 | -3 | 14 |
Free Cash Flow Free Cash FlowCr | 113 | 89 | 125 | 136 | 123 | 82 | 175 | 180 | 158 | -257 | 91 |
CFO To PAT CFO To PAT% | 137.0 | 115.0 | 298.1 | -4,549.4 | 509.4 | 88.4 | 112.3 | 125.7 | 161.5 | -121.8 | -194.8 |
CFO To EBITDA CFO To EBITDA% | 65.8 | 56.6 | 91.0 | 172.4 | 99.7 | 36.7 | 53.1 | 62.5 | 64.1 | 95.7 | 135.6 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 112 | 89 | 123 | 132 | 123 | 82 | 174 | 179 | 157 | 95 | 192 | |
| -111 | -171 | -136 | -104 | -56 | -67 | -121 | -208 | -434 | -339 | -102 | |
| -2 | 132 | -39 | -16 | -64 | -30 | -44 | 23 | 280 | 241 | -77 | |
Net Cash Flow Net Cash FlowCr | 0 | 50 | -52 | 12 | 3 | -14 | 8 | -7 | 3 | -3 | 14 |
Free Cash Flow Free Cash FlowCr | 113 | 89 | 125 | 136 | 123 | 82 | 175 | 180 | 158 | -257 | 91 |
CFO To PAT CFO To PAT% | 137.0 | 115.0 | 298.1 | -4,549.4 | 509.4 | 88.4 | 112.3 | 125.7 | 161.5 | -121.8 | -194.8 |
CFO To EBITDA CFO To EBITDA% | 65.8 | 56.6 | 91.0 | 172.4 | 99.7 | 36.7 | 53.1 | 62.5 | 64.1 | 95.7 | 135.6 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 2,653 | 2,303 | 1,942 | 1,868 | 1,929 | 2,659 | 3,470 | 3,000 | 3,027 | 2,152 | 1,522 | 2,143 |
Price To Earnings Price To Earnings | 32.4 | 29.9 | 47.1 | 79.9 | 28.6 | 22.4 | 21.1 | 30.8 | 67.7 | |||
Price To Sales Price To Sales | 2.6 | 2.1 | 1.9 | 1.9 | 1.7 | 2.1 | 2.3 | 1.8 | 1.7 | 1.3 | 0.8 | 1.1 |
Price To Book Price To Book | 4.6 | 3.5 | 2.9 | 2.8 | 2.8 | 3.5 | 3.8 | 2.9 | 2.7 | 2.1 | 1.6 | 2.1 |
EV To EBITDA EV To EBITDA | 16.2 | 15.9 | 16.0 | 27.1 | 17.0 | 13.0 | 11.3 | 11.6 | 15.0 | 31.5 | 18.2 | 18.7 |
GPM GPM% | 60.4 | 61.4 | 60.6 | 59.9 | 63.0 | 64.8 | 63.6 | 60.4 | 59.6 | 59.9 | 60.3 | 60.3 |
OPM OPM% | 16.9 | 14.6 | 12.9 | 7.9 | 11.1 | 18.1 | 21.3 | 17.1 | 13.4 | 6.0 | 7.7 | 8.8 |
NPM NPM% | 8.1 | 7.2 | 4.0 | -0.3 | 2.2 | 7.5 | 10.1 | 8.5 | 5.3 | -4.7 | -5.3 | 1.7 |
ROCE ROCE% | 15.9 | 10.8 | 7.9 | 1.2 | 6.2 | 14.9 | 21.6 | 16.0 | 9.8 | -0.4 | 0.8 | 8.6 |
ROE ROE% | 14.2 | 11.8 | 6.1 | -0.4 | 3.5 | 12.1 | 17.1 | 13.8 | 8.7 | -7.6 | -10.5 | 3.1 |
ROA ROA% | 8.7 | 6.4 | 3.3 | -0.2 | 1.9 | 7.1 | 10.4 | 8.6 | 4.5 | -3.2 | -3.8 | 1.2 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 2,653 | 2,303 | 1,942 | 1,868 | 1,929 | 2,659 | 3,470 | 3,000 | 3,027 | 2,152 | 1,522 | 2,143 |
Price To Earnings Price To Earnings | 32.4 | 29.9 | 47.1 | 79.9 | 28.6 | 22.4 | 21.1 | 30.8 | 67.7 | |||
Price To Sales Price To Sales | 2.6 | 2.1 | 1.9 | 1.9 | 1.7 | 2.1 | 2.3 | 1.8 | 1.7 | 1.3 | 0.8 | 1.1 |
Price To Book Price To Book | 4.6 | 3.5 | 2.9 | 2.8 | 2.8 | 3.5 | 3.8 | 2.9 | 2.7 | 2.1 | 1.6 | 2.1 |
EV To EBITDA EV To EBITDA | 16.2 | 15.9 | 16.0 | 27.1 | 17.0 | 13.0 | 11.3 | 11.6 | 15.0 | 31.5 | 18.2 | 18.7 |
GPM GPM% | 60.4 | 61.4 | 60.6 | 59.9 | 63.0 | 64.8 | 63.6 | 60.4 | 59.6 | 59.9 | 60.3 | 60.3 |
OPM OPM% | 16.9 | 14.6 | 12.9 | 7.9 | 11.1 | 18.1 | 21.3 | 17.1 | 13.4 | 6.0 | 7.7 | 8.8 |
NPM NPM% | 8.1 | 7.2 | 4.0 | -0.3 | 2.2 | 7.5 | 10.1 | 8.5 | 5.3 | -4.7 | -5.3 | 1.7 |
ROCE ROCE% | 15.9 | 10.8 | 7.9 | 1.2 | 6.2 | 14.9 | 21.6 | 16.0 | 9.8 | -0.4 | 0.8 | 8.6 |
ROE ROE% | 14.2 | 11.8 | 6.1 | -0.4 | 3.5 | 12.1 | 17.1 | 13.8 | 8.7 | -7.6 | -10.5 | 3.1 |
ROA ROA% | 8.7 | 6.4 | 3.3 | -0.2 | 1.9 | 7.1 | 10.4 | 8.6 | 4.5 | -3.2 | -3.8 | 1.2 |
| Market CapitalizationMkt CapCr | 2,901 | 2,757 | 2,175 | 2,143 | 1,841 | 1,593 | 1,482 |
| Close PriceClose₹ | 1,693.90 | 317.05 | 492.30 | 232.15 | 1,655.40 | 2,312.00 | 512.65 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 51.49 | 32.48 | 82.46 | 67.68 | 33.99 | 25.87 | |
| Price To SalesPS | 3.34 | 3.66 | 3.26 | 1.12 | 4.14 | 4.04 | 2.80 |
| RevenueRevenueCr | 870 | 753 | 668 | 1,909 | 444 | 395 | 529 |
| Revenue Growth TTMRev Gr TTM% | 30.1% | 10.6% | 15.2% | 10.6% | 12.6% | ||
| PAT Growth TTMPAT Gr TTM% | -64.3% | 127.6% | 27.3% | 64.3% | 1.0% |
| Market CapitalizationMkt CapCr | 2,901 | 2,757 | 2,175 | 2,143 | 1,841 | 1,593 | 1,482 |
| Close PriceClose₹ | 1,693.90 | 317.05 | 492.30 | 232.15 | 1,655.40 | 2,312.00 | 512.65 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 51.49 | 32.48 | 82.46 | 67.68 | 33.99 | 25.87 | |
| Price To SalesPS | 3.34 | 3.66 | 3.26 | 1.12 | 4.14 | 4.04 | 2.80 |
| RevenueRevenueCr | 870 | 753 | 668 | 1,909 | 444 | 395 | 529 |
| Revenue Growth TTMRev Gr TTM% | 30.1% | 10.6% | 15.2% | 10.6% | 12.6% | ||
| PAT Growth TTMPAT Gr TTM% | -64.3% | 127.6% | 27.3% | 64.3% | 1.0% |